CI— Cigna Group

Health Care$72.4B mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Revenues	—	—	—	$10.88B
Premiums	$40.26B-12.5%	$46.00B+4.0%	$44.24B+10.8%	$39.92B
Net investment income	$1.05B+7.5%	$973.0M-16.6%	$1.17B+1.0%	$1.16B
TOTAL REVENUES	$274.90B+11.2%	$247.12B+26.6%	$195.26B+8.2%	$180.52B
Pharmacy and other service costs	$214.99B+17.8%	$182.51B+36.4%	$133.80B+7.2%	$124.83B
Medical costs and other benefit expenses	$34.35B-11.1%	$38.65B+6.5%	$36.29B+12.7%	$32.18B
Selling, general and administrative expenses	$14.62B-1.5%	$14.84B+0.1%	$14.82B+12.5%	$13.17B
Amortization of acquired intangible assets	$1.74B+2.3%	$1.70B-6.4%	$1.82B-3.0%	$1.88B
TOTAL BENEFITS AND EXPENSES	$265.70B+11.8%	$237.70B+27.3%	$186.73B+8.5%	$172.07B
Income from operations	$9.20B-2.3%	$9.42B+10.3%	$8.54B+1.0%	$8.45B
Interest expense and other	-$1.41B+1.9%	-$1.44B+0.8%	-$1.45B-17.8%	-$1.23B
Net gain (loss) on sale of businesses	$13.0M-45.8%	$24.0M+101.6%	-$1.50B-190.2%	$1.66B
Net investment losses	-$24.0M+99.1%	-$2.74B-3409.0%	-$78.0M+84.0%	-$487.0M
Income before income taxes	$7.78B+47.7%	$5.27B-4.4%	$5.51B-34.3%	$8.40B
TOTAL INCOME TAXES	$1.49B+0.1%	$1.49B+957.4%	$141.0M-91.3%	$1.61B
Net income	$6.29B+66.4%	$3.78B-29.7%	$5.37B-20.8%	$6.78B
Less: Net income attributable to noncontrolling interests	$331.0M-3.8%	$344.0M+65.4%	$208.0M+166.7%	$78.0M
SHAREHOLDERS' NET INCOME	$5.96B+73.5%	$3.43B-33.5%	$5.16B-23.0%	$6.70B
Basic (in dollars per share)	$22330000.00+82.3%	$12250000.00-30.3%	$17570000.00-18.9%	$21660000.00
Diluted (in dollars per share)	$22180000.00+83.0%	$12120000.00-30.3%	$17390000.00-18.8%	$21410000.00
Pharmacy revenues
Revenue from contract with customer	$216.67B+16.9%	$185.36B+35.1%	$137.24B+6.7%	$128.57B
Fees and other revenues

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 12 more years of annual history and full quarterly detail on Pro.

Upgrade to Pro →

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.